World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 20 May 2013
Main ID:  NCT01217658
Date of registration: 06/10/2010
Primary sponsor: The University of Texas Health Science Center, Houston
Public title: Measuring and Reducing Excessive Infant Crying UTHealth THB
Scientific title: Measuring and Reducing Excessive Infant Crying: A Randomized Trial
Date of first enrolment: January 2011
Target sample size: 180
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01217658
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Christopher S Greeley, MD
Address: 
Telephone: 713-500-6643
Email: Christopher.S.Greeley@uth.tmc.edu
Affiliation: 
Name:   Christopher S Greeley, MD
Address: 
Telephone: 713-500-6643
Email: Christopher.S.Greeley@uth.tmc.edu
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- term, singleton neonates

- otherwise healthy

- parent must have at least a 6th grade understanding of English or Spanish

- infant must have colic (greater than 3 hours of crying per day)

- OR the infant's crying causes excessive stress on the either parent

Exclusion Criteria:

- cannot have a condition which would reasonably impact alertness or behavior



Age minimum: N/A
Age maximum: 5 Weeks
Gender: Both
Health Condition(s) or Problem(s) studied
Infant Colic
Postpartum Depression
Intervention(s)
Behavioral: AAP Infant Colic counseling
Behavioral: The Happiest Baby on The Block
Primary Outcome(s)
Mean night-time crying [Time Frame: 2 weeks after enrollment. Appproximately 6-8 weeks of life.]
Mean sleep duration [Time Frame: 2 weeks after enrollment. Appproximately 6-8 weeks of life.]
Secondary Outcome(s)
Maternal Depression, Anxiety and Somatization [Time Frame: At study entry and conculsion (4 week interval); 2 weeks after enrollment. Appproximately 6-8 weeks of life.]
Salivary Biomarkers [Time Frame: At Study Entry and at 2 weeks after enrollment]
Secondary ID(s)
HSC-MS-10-0392
K23HD065872
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institutes of Health (NIH)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history